Immediate Impact

38 standout
Sub-graph 1 of 19

Citing Papers

Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy
2025 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
2 intermediate papers

Works of Ivette Essers being referenced

The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study
2014

Author Peers

Author Last Decade Papers Cites
Ivette Essers 456 283 126 19 521
Suchitrita S. Rathmann 372 253 197 22 543
Imke Redeker 483 224 146 34 580
Renise Ayearst 424 370 164 12 620
Nick Barkham 499 308 166 25 548
L. Linares 337 220 113 26 488
J. Sieper 507 275 129 15 569
Andreas Gerards 425 132 172 19 516
S-K Kwok 327 207 47 22 490
Leonieke van Mens 410 312 188 29 497
Rik Joos 374 133 209 28 583

All Works

Loading papers...

Rankless by CCL
2026